193 related articles for article (PubMed ID: 8893923)
1. Proliferating cell nuclear antigen (PCNA) expression in pseudoepitheliomatous hyperplasia, keratoacanthoma and squamous cell carcinoma of the skin.
Li J; Lee YS
Ann Acad Med Singap; 1996 Jul; 25(4):526-30. PubMed ID: 8893923
[TBL] [Abstract][Full Text] [Related]
2. Proliferating cell nuclear antigen immunostaining in keratoacanthoma and squamous cell carcinoma of the skin.
Royds JA; Stephenson TJ; Silcocks PB; Bleehen SS
Pathologica; 1994 Dec; 86(6):612-6. PubMed ID: 7617390
[TBL] [Abstract][Full Text] [Related]
3. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors.
Cain CT; Niemann TH; Argenyi ZB
Am J Dermatopathol; 1995 Aug; 17(4):324-31. PubMed ID: 8600793
[TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen distribution in keratoacanthoma and squamous cell carcinoma.
Phillips P; Helm KF
J Cutan Pathol; 1993 Oct; 20(5):424-8. PubMed ID: 7507945
[TBL] [Abstract][Full Text] [Related]
5. Keratoacanthoma and squamous cell carcinoma: study of PCNA and Le(Y) expression.
Tsuji T
J Cutan Pathol; 1997 Aug; 24(7):409-15. PubMed ID: 9274958
[TBL] [Abstract][Full Text] [Related]
6. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
Lu S; Tiekso J; Hietanen S; Syrjänen K; Havu VK; Syrjänen S
Acta Derm Venereol; 1999 Jul; 79(4):268-73. PubMed ID: 10429981
[TBL] [Abstract][Full Text] [Related]
7. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
8. Expression of minichromosome maintenance 5 protein in proliferative and malignant skin diseases.
Liu H; Takeuchi S; Moroi Y; Lin N; Urabe K; Kokuba H; Imafuku S; Dainichi T; Uchi H; Furue M; Tu Y
Int J Dermatol; 2007 Nov; 46(11):1171-6. PubMed ID: 17988337
[TBL] [Abstract][Full Text] [Related]
9. An assessment of the malignant potential of actinic keratoses and Bowen's disease: p53 and PCNA expression pattern correlate with the number of desmosomes.
Ramzi ST; Maruno M; Khaskhely NM; Khan MA; Takamiyagi A; Uezato H; Nonaka S
J Dermatol; 2002 Sep; 29(9):562-72. PubMed ID: 12392064
[TBL] [Abstract][Full Text] [Related]
10. Expression of proliferating cell nuclear antigen (PCNA) and apoptosis related antigen (LeY) in epithelial skin tumors.
Tsuji T; Kitajima S; Koashi Y
Am J Dermatopathol; 1998 Apr; 20(2):164-9. PubMed ID: 9557786
[TBL] [Abstract][Full Text] [Related]
11. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
Sakiz D; Turkmenoglu TT; Kabukcuoglu F
Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
[TBL] [Abstract][Full Text] [Related]
12. Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes.
Takahara M; Chen S; Kido M; Takeuchi S; Uchi H; Tu Y; Moroi Y; Furue M
J Cutan Pathol; 2009 Jun; 36(6):668-74. PubMed ID: 19515046
[TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of Langerhans cells in actinic keratosis, Bowen's disease, keratoacanthoma, squamous cell carcinoma and basal cell carcinoma.
McArdle JP; Knight BA; Halliday GM; Muller HK; Rowden G
Pathology; 1986 Apr; 18(2):212-6. PubMed ID: 3763243
[TBL] [Abstract][Full Text] [Related]
14. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
[TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen (PCNA) in common epidermal lesions. An immunohistochemical study of proliferating cell populations.
Geary WA; Cooper PH
J Cutan Pathol; 1992 Dec; 19(6):458-68. PubMed ID: 1362576
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.
Krunic AL; Garrod DR; Madani S; Buchanan MD; Clark RE
Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833
[TBL] [Abstract][Full Text] [Related]
18. Cell apoptosis as assessed by M30 expression in keratoacanthoma and squamous cell carcinoma.
Batinac T; Zamolo G; Brumini G; Biljan D; Petranović D; Troselj-Vukić B
Coll Antropol; 2008 Jun; 32(2):499-504. PubMed ID: 18756900
[TBL] [Abstract][Full Text] [Related]
19. [Actinic keratosis, Bowen's disease, keratoacanthoma and squamous cell carcinoma of the skin].
Majores M; Bierhoff E
Pathologe; 2015 Feb; 36(1):16-29. PubMed ID: 25663185
[TBL] [Abstract][Full Text] [Related]
20. DNA content and proliferative index in cutaneous squamous cell carcinoma and keratoacanthoma.
Randall MB; Geisinger KR; Kute TE; Buss DH; Prichard RW
Am J Clin Pathol; 1990 Feb; 93(2):259-62. PubMed ID: 2301286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
